Genetic and immunological therapy for cancer

This publication has 10 references indexed in Scilit:

• Rapid Death of Adoptively Transferred T Cells in Acquired Immunodeficiency Syndrome
  Blood, 1999
• Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression
  Nature Medicine, 1998
• A phase I clinical trial of immunotherapy with interferon-? gene-modified autologous melanoma cells
  Cancer, 1997
• Biology and adoptive cell therapy of Epstein‐Barr virus‐associated lymphoproliferative disorders in recipients of marrow allografts
  Immunological Reviews, 1997
• Antigens recognized by T-lymphocytes on human tumours
  Biochemical Society Transactions, 1997
• Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA–liposome complexes
  Proceedings of the National Academy of Sciences, 1996
• Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.
  Nature Medicine, 1996
• Phase I Study of Recombinant CEA Vaccinia Virus Vaccine with Post Vaccination CEA Peptide Challenge. Medical University of South Carolina, Charleston, South Carolina
  Human Gene Therapy, 1996
• Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
  New England Journal of Medicine, 1995
• Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
  Proceedings of the National Academy of Sciences, 1993